Tagged with Mark von Itzstein

Vaginal microbes are at the centre of a novel discovery that aims to investigate if these bacteria trap HIV or act as a courier service to deliver the virus to the host within the human body.

Griffith University researchers are making inroads in ovarian cancer research looking at early detection signs and how the disease spreads through the body.

A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a Strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen which kills more than 500,000 people each year.

A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.

Griffith University has launched two cancer research centres backed by $4.6 million in funding from the Australian Cancer Research Foundation this month.

New research has successfully switched off a key pathway of nerve fibre breakdown in debilitating neurodegenerative disorders

Institute for Glycomics researchers awarded $1.1 million from NHMRC to develop new antibiotics for drug resistant gonorrhoea.